Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The closing price of Co-Diagnostics Inc (NASDAQ: CODX) was $0.23 for the day, down -2.41% from the previous closing price of $0.24. In other words, the price has decreased by -$2.41 from its previous closing price. On the day, 1.23 million shares were traded. CODX stock price reached its highest trading level at $0.2451 during the session, while it also had its lowest trading level at $0.2234.
Ratios:
Our analysis of CODX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 3.51 and its Current Ratio is at 3.81. In the meantime, Its Debt-to-Equity ratio is 0.04 whereas as Long-Term Debt/Eq ratio is at 0.02.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CODX now has a Market Capitalization of 14309757 and an Enterprise Value of 4337913. For the stock, the TTM Price-to-Sale (P/S) ratio is 28.06 while its Price-to-Book (P/B) ratio in mrq is 0.28. Its current Enterprise Value per Revenue stands at 8.541 whereas that against EBITDA is -0.126.
Stock Price History:
The Beta on a monthly basis for CODX is 1.20, which has changed by -0.6642857 over the last 52 weeks, in comparison to a change of 0.17318606 over the same period for the S&P500. Over the past 52 weeks, CODX has reached a high of $1.55, while it has fallen to a 52-week low of $0.23. The 50-Day Moving Average of the stock is -36.30%, while the 200-Day Moving Average is calculated to be -30.32%.
Shares Statistics:
CODX traded an average of 20.51M shares per day over the past three months and 1901460 shares per day over the past ten days. A total of 60.89M shares are outstanding, with a floating share count of 55.51M. Insiders hold about 8.84% of the company’s shares, while institutions hold 15.42% stake in the company. Shares short for CODX as of 1765756800 were 646208 with a Short Ratio of 0.03, compared to 1763078400 on 1708244. Therefore, it implies a Short% of Shares Outstanding of 646208 and a Short% of Float of 1.1199999999999999.
Earnings Estimates
The company has 2.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.12, with high estimates of -$0.12 and low estimates of -$0.13.
Analysts are recommending an EPS of between -$0.68 and -$0.72 for the fiscal current year, implying an average EPS of -$0.7. EPS for the following year is -$0.41, with 2 analysts recommending between -$0.36 and -$0.45.
Revenue Estimates
It is expected that $90B in revenue will be generated in. The current quarter, according to 2 analysts. It ranges from a high estimate of $150k to a low estimate of $102k. As of. The current estimate, Co-Diagnostics Inc’s year-ago sales were $149.33kFor the next quarter, 2 analysts are estimating revenue of $163.5k. There is a high estimate of $200k for the next quarter, whereas the lowest estimate is $127k.
A total of 2 analysts have provided revenue estimates for CODX’s current fiscal year. The highest revenue estimate was $509k, while the lowest revenue estimate was $460k, resulting in an average revenue estimate of $484.5k. In the same quarter a year ago, actual revenue was $3.92MBased on 2 analysts’ estimates, the company’s revenue will be $576k in the next fiscal year. The high estimate is $600k and the low estimate is $552k.
